Health Care News and Ideas for Medical Conference Organizers

INDUSTRY NOTES A biotech startup will team up with Merck to educate physicians about HIV drug-resistance testing. ViroLogic Inc. and Merck & Co. Inc. will jointly develop and execute educational programs on the utility of HIV drug-resistance testing for physicians across the nation. ViroLogic is a South San Francisco, Calif.-based biotechnology company specializing in developing treatments for serious viral, immunologic, and oncologic diseases.

ViroLogic and Merck will conduct a s

Register to view the full article

Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish